Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies

BACKGROUND: Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed tofacitinib efficacy on enthesitis by baseline location and severity, and impact on disease activity and patient-reported outcomes (PROs), in patients with PsA. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip J., Orbai, Ana-Maria, FitzGerald, Oliver, Bedaiwi, Mohamed, Dona L. Fleishaker, Mundayat, Rajiv, Young, Pamela, Helliwell, Philip S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464128/
https://www.ncbi.nlm.nih.gov/pubmed/37608391
http://dx.doi.org/10.1186/s13075-023-03108-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464128/
https://www.ncbi.nlm.nih.gov/pubmed/37608391
http://dx.doi.org/10.1186/s13075-023-03108-5

Ejemplares similares